{
  "created_at": "Sat Jan 30 2:53:43 +0000 2021",
  "id_str": "1355303234815057927",
  "full_text": "Several vaccine-makers are already working on modified jabs that target the B.1.351 variant crushing South Africa https://t.co/lvYfkf7OaH",
  "display_text_range": [
    0,
    137
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/lvYfkf7OaH",
        "expanded_url": "https://econ.st/2YqLnur",
        "display_url": "econ.st/2YqLnur",
        "indices": [
          114,
          137
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 29,
  "favorite_count": 95,
  "possibly_sensitive": false,
  "original_created_at": "Fri Jan 29 23:54:06 +0000 2021",
  "localize": [
    {
      "locale": "zh",
      "full_text": "几家疫苗制造商已经在研究针对B.1.351变种粉碎南非的改良疫苗https://t.co/lvYfkf7OaH。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "幾家疫苗製造商已經在研究針對B.1.351變種粉碎南非的改良疫苗https://t.co/lvYfkf7OaH。"
    }
  ]
}